ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BioDelivery Sciences to Acquire U.S. and Canadian Rights to ELYXYB™ for Migraine Treatment
August 05, 2021BioDelivery Sciences International Inc., a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, announced that it entered into an agreement on August 3, 2021 with Dr. Reddy’s Laboratories ... -
Two anti-inflammatory drugs may inhibit COVID-19 virus reproduction
May 29, 2020The findings show that at a concentration of 50 micromolar (μM) of Celecoxib or Carprofen, the inhibition of the in vitro activity of M-pro enzyme is 11.90 and 4.0 per cent, respectively. -
Celecoxib shows potential benefit for Duchenne muscular dystrophy
May 09, 2018Researchers have found that the FDA-approved anti-inflammatory drug Celecoxib had beneficial effects on the muscle function in muscular dystrophy…
Pharma Sources Insight January 2025
